ABZYME RESEARCH FOUNDATION
Data sourced from IRS 990 public filings
ABZYME RESEARCH FOUNDATION THE SUCCESSFUL COMPLETION OF THE PRE-INVESTIGATIONAL NEW DRUG MEETING WITH THE FDA AS WELLAS THE INITIATION OF A SCALE-UP OF THE MANUFACTURING OF THE VACCINE COMPOUND.
ABZYME RESEARCH FOUNDATION has received 22 grants from 9 known foundation funders. Revenue increased from $10,001 in 2024 to $164,001 in 2025. Most recent reported revenue: $164,001.
Annual Revenue
$164,001
Known Funders
9
Grants Received
22
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $164,001 | $142,754 | $357,202 |
| 2024 | $10,001 | $3,682 | $335,298 |
| 2023 | $23 | $7,223 | $328,979 |
| 2022 | $52 | $5,739 | $336,178 |
Top Funders
NASHVILLE, TN
NASHVILLE, TN
NEEDHAM, MA
SEATTLE, WA
NASHVILLE, TN
NEEDHAM, MA
SAN ANTONIO, TX
NEEDHAM, MA
NEEDHAM, MA
SEATTLE, WA
Key Personnel
From 2025 IRS 990 filing
BETH MILLER SAKS
Director
VALERIE KERR
Director
ZACHARY BARNETT
Director
NICHOLAS SMITH
Treasurer
AIMEE A DROUIN
Secretary
MICHAEL JEFVERT
Chairman
ADAM MACLEAN
Chairman
TIM VOLK
Director
Frequently Asked Questions
Other Nonprofits in New York
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.